BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21660702)

  • 1. Understanding the immunoglobulin locus specificity of hypermutation.
    Batrak V; Blagodatski A; Buerstedde JM
    Methods Mol Biol; 2011; 745():311-26. PubMed ID: 21660702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible switching of immunoglobulin hypermutation machinery in a chicken B cell line.
    Kanayama N; Todo K; Reth M; Ohmori H
    Biochem Biophys Res Commun; 2005 Feb; 327(1):70-5. PubMed ID: 15629431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
    Rückerl F; Busse B; Bachl J
    Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation.
    Blagodatski A; Batrak V; Schmidl S; Schoetz U; Caldwell RB; Arakawa H; Buerstedde JM
    PLoS Genet; 2009 Jan; 5(1):e1000332. PubMed ID: 19132090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin gene conversion: insights from bursal B cells and the DT40 cell line.
    Arakawa H; Buerstedde JM
    Dev Dyn; 2004 Mar; 229(3):458-64. PubMed ID: 14991701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion.
    Arakawa H; Hauschild J; Buerstedde JM
    Science; 2002 Feb; 295(5558):1301-6. PubMed ID: 11847344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recruitment of activation induced cytidine deaminase to the immunoglobulin locus by a regulatory element.
    Kim Y; Tian M
    Mol Immunol; 2010 May; 47(9):1860-5. PubMed ID: 20334924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of core DNA elements that target somatic hypermutation.
    Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
    J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
    Hadzidimitriou A; Stamatopoulos K; Belessi C; Lalayianni C; Stavroyianni N; Smilevska T; Hatzi K; Laoutaris N; Anagnostopoulos A; Kollia P; Fassas A
    Haematologica; 2006 Jun; 91(6):781-7. PubMed ID: 16769580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced cytidine deaminase-mediated hypermutation in the DT40 cell line.
    Arakawa H; Buerstedde JM
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):639-44. PubMed ID: 19008193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.
    Bye JM; Carter C; Cui Y; Gorick BD; Songsivilai S; Winter G; Hughes-Jones NC; Marks JD
    J Clin Invest; 1992 Dec; 90(6):2481-90. PubMed ID: 1469099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed molecular evolution by somatic hypermutation.
    Wang CL; Yang DC; Wabl M
    Protein Eng Des Sel; 2004 Sep; 17(9):659-64. PubMed ID: 15516361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect and direct evidence for DNA double-strand breaks in hypermutating immunoglobulin genes.
    Jacobs H; Rajewsky K; Fukita Y; Bross L
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):119-25. PubMed ID: 11205324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
    Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
    Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vectors to monitor somatic hypermutation.
    Klasen M; Spillmann FJ; Lorens JB; Wabl M
    J Immunol Methods; 2005 May; 300(1-2):47-62. PubMed ID: 15936027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A backup role of DNA polymerase kappa in Ig gene hypermutation only takes place in the complete absence of DNA polymerase eta.
    Faili A; Stary A; Delbos F; Weller S; Aoufouchi S; Sarasin A; Weill JC; Reynaud CA
    J Immunol; 2009 May; 182(10):6353-9. PubMed ID: 19414788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
    Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
    PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic hypermutation and B-cell lymphoma.
    Dunn-Walters D; Thiede C; Alpen B; Spencer J
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.